Gene therapy recipients monitored for hidden side effects
NCT ID NCT02390297
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 27 times
Summary
This study is a long-term safety follow-up for 11 HIV patients who previously received a gene therapy called Cal-1. The goal is to watch for any delayed side effects from the treatment and to see how long the modified cells survive in the body. Participants are not receiving new treatment, just being monitored over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Quest Clinical Research
San Francisco, California, 94115, United States
-
UCLA CARE Center
Los Angeles, California, 90035, United States
Conditions
Explore the condition pages connected to this study.